NEW YORK (GenomeWeb) – Sigma-Aldrich today said that its pending $17 billion acquisition by Merck KGaA has cleared US antitrust hurdles. 

The waiting period under the Hart-Scott-Rodino Antitrust Improvement Act for the proposed deal expired on Monday, clearing the way for the deal in theUS. Sigma-Aldrich and Merck KGaA are awaiting regulatory approval in other countries but continue to expect the deal to be completed in mid-2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.